It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
5-Methylcytosine (m5C) is a common RNA modification that modulates gene expression at the posttranscriptional level, but the crosstalk between m5C RNA modification and biomolecule condensation, as well as transcription factor-mediated transcriptional regulation, in ovarian cancer, is poorly understood. In this study, we revealed that the RNA methyltransferase NSUN2 facilitates mRNA m5C modification and forms a positive feedback regulatory loop with the transcription factor E2F1 in ovarian cancer. Specifically, NSUN2 promotes m5C modification of E2F1 mRNA and increases its stability, and E2F1 binds to the NSUN2 promoter, subsequently reciprocally activating NSUN2 transcription. The RNA binding protein YBX1 functions as the m5C reader and is involved in NSUN2-mediated E2F1 regulation. m5C modification promotes YBX1 phase separation, which upregulates E2F1 expression. In ovarian cancer, NSUN2 and YBX1 are amplified and upregulated, and higher expression of NSUN2 and YBX1 predicts a worse prognosis for ovarian cancer patients. Moreover, E2F1 transcriptionally regulates the expression of the oncogenes MYBL2 and RAD54L, driving ovarian cancer progression. Thus, our study delineates a NSUN2-E2F1-NSUN2 loop regulated by m5C modification in a manner dependent on YBX1 phase separation, and this previously unidentified pathway could be a promising target for ovarian cancer treatment.
m5C modification: a new pathway in ovarian cancer treatment
Ovarian cancer is the most lethal women’s reproductive system cancer globally, largely due to the absence of early detection techniques. Scientists have discovered that a gene named NSUN2, often found in excess in ovarian cancer, is vital for the cancer’s growth. The research, led by P.Y. and T.L., revealed that NSUN2 encourages the expansion and spread of ovarian cancer cells. They also found that NSUN2 controls the activity of another gene, E2F1, through a method called m5C modification (a process that alters gene expression). This method is essential for E2F1’s RNA stability, a significant factor in cancer growth. The study indicates that focusing on NSUN2 and E2F1 could be a potential treatment approach for ovarian cancer. This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 The Third Affiliated Hospital of Chongqing Medical University, Department of Obstetrics and Gynecology, Chongqing, China (GRID:grid.203458.8) (ISNI:0000 0000 8653 0555)
2 The Third Affiliated Hospital of Chongqing Medical University, Department of Obstetrics and Gynecology, Chongqing, China (GRID:grid.203458.8) (ISNI:0000 0000 8653 0555); Children’s Hospital of Chongqing Medical University, Chongqing Key Laboratory of Child Infection and Immunity, Chongqing, China (GRID:grid.488412.3)
3 Army Medical University, Department of Pathology, Southwest Hospital, Chongqing, China (GRID:grid.410570.7) (ISNI:0000 0004 1760 6682)
4 Army Medical University, Department of Obstetrics and Gynecology, Daping Hospital, Chongqing, China (GRID:grid.410570.7) (ISNI:0000 0004 1760 6682)
5 Chongqing Medical University, Institute of Life Sciences, Chongqing, China (GRID:grid.203458.8) (ISNI:0000 0000 8653 0555)
6 City of Hope National Medical Center, Department of Hematology and Hematopoietic Cell Transplantation, Duarte, USA (GRID:grid.410425.6) (ISNI:0000 0004 0421 8357)